TRIFLUOPERAZINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Trifluoperazine, and when can generic versions of Trifluoperazine launch?
Trifluoperazine is a drug marketed by Chartwell Rx, Wockhardt, Duramed Pharms Barr, Ivax Pharms, Mylan, Pom Pharma, Sandoz, and Watson Labs. and is included in twenty NDAs.
The generic ingredient in TRIFLUOPERAZINE is trifluoperazine hydrochloride. There are ten drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the trifluoperazine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Trifluoperazine
A generic version of TRIFLUOPERAZINE was approved as trifluoperazine hydrochloride by SANDOZ on December 31st, 1969.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for TRIFLUOPERAZINE?
- What are the global sales for TRIFLUOPERAZINE?
- What is Average Wholesale Price for TRIFLUOPERAZINE?
Summary for TRIFLUOPERAZINE
| US Patents: | 0 |
| Applicants: | 8 |
| NDAs: | 20 |
| Drug Prices: | Drug price information for TRIFLUOPERAZINE |
| DailyMed Link: | TRIFLUOPERAZINE at DailyMed |
US Patents and Regulatory Information for TRIFLUOPERAZINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chartwell Rx | TRIFLUOPERAZINE HYDROCHLORIDE | trifluoperazine hydrochloride | CONCENTRATE;ORAL | 085787-001 | Apr 15, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Pom Pharma | TRIFLUOPERAZINE HYDROCHLORIDE | trifluoperazine hydrochloride | TABLET;ORAL | 040153-004 | Oct 25, 1996 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Watson Labs | TRIFLUOPERAZINE HYDROCHLORIDE | trifluoperazine hydrochloride | TABLET;ORAL | 085976-001 | Jun 23, 1988 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
